Novabridge Biosciences (NBP) 13F Holdings Overview (Q2 2026)

NBP ranks #6220 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

NBP is a top-conviction position for AIHC Capital Management Ltd — at 5.4% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in NBP belongs to Hhlr Advisors, LTD., but the position matters far more to AIHC Capital Management Ltd, who has 5.4% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

AIHC Capital Management Ltd has added to its NBP position for two straight quarters, increasing it by $4.0M to reach $5.6M today.

Hhlr Advisors, LTD. has trimmed its NBP position for two straight quarters, cutting it by $12.1M while still holding $11.7M.

NBP is up 3.5% today, and institutions have been net buyers of $6.5M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

NBP reported a net loss of $46.3M in its latest fiscal year.

• Not yet profitable — net loss of $46.3M in the latest fiscal year
• Net income declined year over year, from -$22.2M to -$46.3M
• Operating cash flow was negative, using $20.6M in cash
• Current ratio of 8.09x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.13x equity — within a conventional range